The seven-year, sole-source agreement includes more than 240 ACL TOP Family 50 Series Hemostasis Testing Systems, including more than 150 competitive instruments, as well as several HemoCell Specialized Lab Automation installations.
Following many months of hard work and persistence, weekly meetings with the system’s leadership, and a visit to Werfen’s VIP booth at the Association for Diagnostics & Laboratory Medicine (formerly AACC), the Werfen team prevailed, despite aggressive competition.
Congratulations to the Werfen team in North America for this monumental success!